↓ Skip to main content

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy

Overview of attention for article published in Cancer Immunology, Immunotherapy, April 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

patent
40 patents

Citations

dimensions_citation
1052 Dimensions

Readers on

mendeley
517 Mendeley
citeulike
1 CiteULike
Title
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
Published in
Cancer Immunology, Immunotherapy, April 2008
DOI 10.1007/s00262-008-0523-4
Pubmed ID
Authors

C. Marcela Diaz-Montero, Mohamed Labib Salem, Michael I. Nishimura, Elizabeth Garrett-Mayer, David J. Cole, Alberto J. Montero

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 517 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 <1%
Germany 3 <1%
India 1 <1%
Philippines 1 <1%
Unknown 509 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 105 20%
Researcher 83 16%
Student > Master 65 13%
Student > Bachelor 59 11%
Student > Doctoral Student 37 7%
Other 82 16%
Unknown 86 17%
Readers by discipline Count As %
Medicine and Dentistry 126 24%
Agricultural and Biological Sciences 88 17%
Immunology and Microbiology 79 15%
Biochemistry, Genetics and Molecular Biology 63 12%
Pharmacology, Toxicology and Pharmaceutical Science 14 3%
Other 38 7%
Unknown 109 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 October 2023.
All research outputs
#2,031,227
of 26,017,215 outputs
Outputs from Cancer Immunology, Immunotherapy
#65
of 3,029 outputs
Outputs of similar age
#5,049
of 92,512 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#1
of 24 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,029 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 92,512 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.